InsidersTradesSigma
Discover the full record of transactions filed by DeFrancesco Lisa, Director. Insider active across 1 companies, notably Intercept Pharmaceuticals, INC.. Aggregated, 6 reports have been recorded. The latest transaction was filed on 31 December 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
6 of 6 declarations
Lisa DeFrancesco is SVP of Investor Relations and Corporate Affairs at INTERCEPT PHARMACEUTICALS, INC. She oversees communications with investors and contributes to the company's strategy. Her role is essential in ensuring transparency and investor trust.